Monensin may inhibit melanoma by regulating the selection between differentiation and stemness of melanoma stem cells

PeerJ
Haoran XinFang Deng

Abstract

Melanoma is the most lethal cutaneous malignancy that threatens human lives. Poor sensitivity to chemotherapy drugs and the high rate of resistance are the bottlenecks of melanoma treatment. Thus, new chemotherapy drugs are needed. Drug repurposing is a safe, economical and timesaving way to explore new chemotherapy for diseases. Here, we investigated the possibility of repurposing the antibiotic monensin as an anti-melanoma agent. Using three human melanoma cells and two nomal human cell lines as cell models, we found that monensin is obviously toxic to human melanoma cells while safe to nomal human cells. It effectively inhibited cell proliferation and viability, while promoted apoptosis and differentiation of human melanoma cells in vitro. By establishment of an animal model of transplanted human melanoma in nude mice, we demonstrated that monensin suppressed the growth of xenografts in vivo. At the same time, we found that melanogenesis increased and the ability of sphere and cloning forming of melanoma decreased under the treatment of monensin. Further detection about differentiation and pluripotent regulations were executed. Our results suggest that monensin is a potent inhibitor of melanoma, and its anti-tumor mechanism ...Continue Reading

References

Sep 5, 2002·International Journal of Cancer. Journal International Du Cancer·Woo H ParkYoung Y Lee
Apr 14, 2006·Mayo Clinic Proceedings·Deborah L CumminsArjun Chanmugam
Jun 20, 2012·International Journal of Molecular Medicine·Haiying GuoTian Yang
Feb 26, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A GuptaM R Middleton
Dec 8, 2016·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·V C AmannJ Mangana
Nov 5, 2017·Oncotarget·Merope GriffinSophia N Karagiannis

❮ Previous
Next ❯

Citations

Oct 16, 2021·Experimental and Therapeutic Medicine·Shujuan YaoShiqian Zhang

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
flow cytometry
PCR
xenografts

Software Mentioned

Xenogen Living Image
GraphPad Prism
FlowJo
GraphPad

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis